Feb 4 (Reuters) - AbbVie forecast 2026 profit above Wall Street estimates on Wednesday after posting a fourth-quarter results beat, fueled by strong demand for newer immunology drugs Skyrizi and ...
The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Injectable dermal products have become some of the most sought-after cosmetic treatments. But behind every injection lies a ...
The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
We came across a bullish thesis on AbbVie Inc. on Disruptive Analytics ’ Substack by Magnus Ofstad. In this article, we will ...
A University of Missouri researcher has unveiled a safer, smarter way to fight drug-resistant infections. Dr. Hongmin Sun, an ...
Turmeric and ibuprofen both reduce inflammation and pain, but they work in different ways. Learn how curcumin extract (from ...
Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that ...
Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 ...
This Schedule 1 mixing guide will explain how to get all 34 effects in the game and where to get all of the required ...
Ms. Omar was sprayed with liquid from a syringe as she spoke at a town hall and called for the resignation of Kristi Noem, ...